Login to Your Account

UK MPs call for no limit on drug prices for ultra-orphan diseases

By Nuala Moran
Staff Writer

Thursday, March 13, 2014

LONDON – A majority of members of parliament (MPs) say there should be no limit on the price per patient paid for drugs to treat ultra-orphan diseases, according to a survey commissioned by the UK Bioindustry Association (BIA).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription